Skin cancer



dynaCERT Inc.
Latest Comments
image_pdfimage_print

MedX Health distribution partnership with VidaCeuticals sets the groundwork for a broader market roll-out in Canada

When we last looked at MedX Health Corp. (TSXV: MDX) we talked about how the heavy lifting had been done, […]


World class skin cancer diagnostic technology prepares to treat the world.

Have you ever tried to get a dermatology appointment? I don’t know about anywhere else in the world but in […]


Commercializing their telemedicine platform globally for the early detection of skin cancer, MedX Health revenue (and stock) is rising

MedX Health Corp’s  (TSXV: MDX) (‘MedX’) stock price is beginning to move higher as they gain further success commercializing their […]


A more accurate assessment on skin cancer is the way MedX plans to save the planet

No one should ever die of skin cancer. Wow – doesn’t that just wake you up a little bit? The […]


MedX Health explains why no one should ever die from skin cancer

InvestorIntel’s Tracy Weslosky talks with MedX Health Corp.‘s (TSXV: MDX) Executive Chairman & CEO Robert Von Der Porten and Mike […]


MedX Health continues its global expansion in the fight against skin cancer

Skin cancer is the most common cancer in the United States and worldwide, but early screening can save lives. Did […]


MDSAP certified MedX Health is set to go in Brazil with regulatory approval achieved for their skin cancer diagnosis products

MedX Health Corp. (TSXV: MDX), a leading medical device and software company focused on early detection of skin cancer, is […]